Metabolic Engineering of Escherichia coli for Efficient Production of Pseudouridine

Min Zhou,Ruyu Tang,Liyuan Wei,Jidong Wang,Huan Qi
DOI: https://doi.org/10.1021/acsomega.3c05219
IF: 4.1
2023-10-10
ACS Omega
Abstract:Pseudouridine-incorporated mRNA vaccines can enhance protein expression and reduce immunogenicity, leading to a high demand for pseudouridine to be used in mRNA drug production. To achieve the low-cost production of pseudouridine, Escherichia coli was systematically modified to utilize inexpensive raw materials to efficiently produce pseudouridine. First, in the pyrimidine biosynthesis pathway, genes related to the precursor competing pathway and the negative regulator were deleted, which...
chemistry, multidisciplinary
What problem does this paper attempt to address?
The aim of this paper is to address the problem of producing pseudouridine at low cost and high efficiency by metabolically engineering *Escherichia coli*. Specifically, the research team genetically modified *E. coli* to increase the yield of pseudouridine using inexpensive raw materials. Pseudouridine, as an important component of mRNA vaccines, can enhance protein expression and reduce immunogenicity, leading to a high demand for it. Currently, the main production methods include chemical synthesis, natural biosynthesis, and enzymatic synthesis, but these methods are either costly or have limited yields. To achieve low-cost large-scale production, the research team employed strategies such as deleting genes related to precursor competing pathways and negative regulatory genes, screening for efficient pseudouridine-5′-phosphorylase (psuG) and phosphatase genes, and knocking out genes related to pseudouridine degradation. Ultimately, they achieved a pseudouridine yield of 7.9 g/L in a 5-liter bioreactor, demonstrating the potential for industrial production.